Substance / Medication

Naftifine

Overview

Active Ingredient
naftifine
RxNorm CUI
31476

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Research Evidence

Published studies and systematic reviews

Sort:
A comprehensive evaluation of Naftifine's efficacy and safety in treating dermatophyte infections; systematic review and meta-analysis.
Abo Zeid Mohamed, Elrosasy Amr, Alkousheh Hazim et al. · Arch Dermatol Res · 2025
PMID: 40053133Meta-Analysis
Naftifine Hydrochloride Gel 2%: An Effective Topical Treatment for Moccasin-Type Tinea Pedis.
Stein Gold Linda F, Vlahovic Tracey, Verma Amit et al. · J Drugs Dermatol · 2015
PMID: 26461826Meta-Analysis
Efficacy and Safety of Naftifine HCl Cream 2% in the Treatment of Pediatric Subjects With Tinea Corporis.
Gold Michael, Dhawan Sunil, Verma Amit et al. · J Drugs Dermatol · 2016
PMID: 27272083Observational
An Open-Label, Multi-Center, Multiple-Application Pharmacokinetic Study of Naftifine HCl Gel 2% in Pediatric Subjects With Tinea Pedis.
Verma Amit, Olayinka Babajide, Fleischer Alan B · J Drugs Dermatol · 2015
PMID: 26151784Observational
Allergic contact dermatitis to naftifine.
Corazza Monica, Lauriola Maria Michela, Virgili Annarosa · Contact Dermatitis · 2005
PMID: 16283912Case Report
Protective mechanism of action of the antifungal drug naftifine againstinfection.
Wang Jia, Paroha Ruchi, Sha Jian et al. · Antimicrob Agents Chemother · 2026
PMID: 41532771Other

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Naftifine (substance)
SNOMED CT
372655002
UMLS CUI
C0068367
RxNorm CUI
31476

Clinical Data

This intervention maps to 2 entities in the Healos knowledge graph.

2
Conditions
0
Biomarkers
0
Specialists
0
Symptoms

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.